Lubris BioPharma
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Lubris BioPharma is a biopharmaceutical company that develops a recombinant human protein, lubricin, for the treatment of dry eye, osteoarthritis, and other inflammation-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lubris BioPharma Comparables
Compare Lubris BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TearSolutions | 80% | |
| Novartis | 78% | |
| Stuart Therapeutics, Inc. | 78% |
Lubris BioPharma Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 75% MoM.
- Feb 3, 2026
Monthly visitors increased 46% MoM.
Lubris BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lubris BioPharma's valuation, stock price, and market status.
Is Lubris BioPharma a public or private company?
Lubris BioPharma is a private company.
What is the current stock price of Lubris BioPharma?
Lubris BioPharma is a private company, so its shares have no public market price. Caplight tracks Lubris BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lubris BioPharma worth (valuation)?
Valuation information for Lubris BioPharma is not publicly available.
Can I buy Lubris BioPharma stock?
Lubris BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lubris BioPharma's last funding round?
Funding round information for Lubris BioPharma is not publicly available.
Who are the main investors in Lubris BioPharma?
Investor information for Lubris BioPharma is not publicly disclosed.
Will Lubris BioPharma IPO soon?
No public IPO plans have been announced for Lubris BioPharma.
How can I track Lubris BioPharma secondary market activity?
Caplight tracks bids, offers, and trades in Lubris BioPharma's shares on secondary markets.